In 2016, we isolated the Marseille-P2849 strain from the stool of a 19-year-old healthy Bedouin living in Saudi Arabia. This study was part of an effort to explore the human gut microbiota using culturomics [1] . The patient gave a signed informed consent, and the study was validated by the ethics committee of the Institut Federatif de Recherche 48 under number 09-022.
The bacterium could not be identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) screening (score <0.7) using a Microflex spectrometer (Bruker Daltonics, Bremen, Germany) [2] . Consequently, we sequenced the 16S rRNA gene of the bacterium using fD1 and rP2 primers as previously described [3] .
The stool sample from the Bedouin was subjected in the conditions of culture developed by culturomics [1, 4] . The stool was preincubated for 7 days at 37°C in an anaerobic atmosphere in a culture bottle containing blood-enriched Columbia agar liquid medium (bioMérieux, Marcy l'Etoile, France) supplemented with 5 mL of rumen fluid filtersterilized through a 0.2 μm pore filter (Thermo Fisher Scientific, Villebon sur Yvette, France). The initial growth of the Marseille-P2849 T strain was obtained 4 days after the seeding of the liquid medium in a 5% sheep's blood agar that was incubated at 37°C in anaerobiose generated using AnaeroGen (bioMérieux). Raoultibacter massiliensis forms transparent microcolonies on blood agar with a mean diameter of 0.1 to 0.3 mm. Bacterial cells are motile Gram-negative, short rods/ coccobacilli ranging in length from 0.8 to 1.2 μm with a mean diameter ranging from 0.4 to 0.6 μm. The Marseille-P2849 T strain was found to be a strictly anaerobic, non-spore-forming coccobacilli and was catalase positive and oxidase negative.
The sequence of the 16S rRNA gene of this strain showed a similarity of 91.4% with Gordonibacter urolithinfaciens strain Marseille-AA00211 T and 91.3% with Gordonibacter pamelaeae strain 7-10-1-b T (GenBank accession numbers LT223667 and NR102934, respectively), the phylogenetically closest species with standing in nomenclature ( Fig. 1) , which putatively classifies the bacterium as a member of a new genus within the family Eggerthellaceae that we named "Raoultibacter." Gordonibacter urolithinfaciens and Gordonibacter pamelaeae are anaerobic, non-spore-forming, Gram-positive coccobacilli isolated from the healthy human gut and from the colon of a patient with acute Crohn disease, respectively [5, 6] .
Because strain Marseille-P2849 T exhibits a 16S rRNA sequence divergence of >5% with its phylogenetically closest species with a validly published name with standing in nomenclature [7] , we propose the creation of the new genus named "Raoultibacter" (ra.ou.l.ti.bac'ter, N.L. masc. gen. n. Raoultibacter, composed of Raoulti, in honor of French microbiologist Didier Raoult, who created the concept of culturomics, and bacter, "bacterium"). Marseille-P2849 T is the type strain of the new species "Raoultibacter massiliensis" gen. nov., sp. nov. (mas.il.i.en 0 sis, L. gen. masc. n. massiliensis, "of Massilia," the Latin name of Marseille where the strain Marseille-P2849 T was first isolated).
MALDI-TOF MS spectrum accession number
The MALDI-TOF MS spectrum of "Raoultibacter massiliensis" is available online (http://mediterranee-infection.com/article.php? laref=256&titre=urms-database).
Nucleotide sequence accession number
The 16S rRNA gene sequence was deposited in GenBank under accession number LT576395.
Deposit in a culture collection
Marseille-P2849 T strain was deposited in the Collection de Souches de l'Unité des Rickettsies (CSUR, WDCM 875) under number P2849.
